Newsfeeds - Spark Newswire

3 minute read

Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday’s Mid-Day Session

Today, 12:44 PM

Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.

ABT

1 minute read

ProPhase Labs Q2 EPS $0.48 Up From $(0.09) YoY, Sales $29.09M Beat $20.01M Estimate

By Benzinga Newsdesk

Today, 12:44 PM

ProPhase Labs (NASDAQ:PRPH) reported quarterly earnings of $0.48 per share. This is a 633.33 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of

PRPH

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

Today, 12:44 PM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG

5 minute read

This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday

By Lisa Levin

Today, 12:44 PM

Gainers

AAMC

5 minute read

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday

By Lisa Levin

Today, 12:44 PM

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.

2 minute read

Impact BioMedical Announces License Agreement With ProPhase Labs To Produce And Distribute Viral-Fighting Compound Equivir

By Benzinga Newsdesk

Today, 12:44 PM

Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE:DSS), along with its scientific research partner Global Research and Discovery Group Sciences (GRDG), announced today that it signed a license

DSS

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 12:44 PM

Gainers

ACRX

3 minute read

The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio’s PRV; RMAT Designation For PolarityTE’s Product

By Vandana Singh

Today, 12:44 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

BBIO

1 minute read

Recap: ProPhase Labs Q1 Earnings

By Benzinga Insights

Today, 12:44 PM

ProPhase Labs (NASDAQ:PRPH) reported its Q1 earnings results on Friday, May 13, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

PRPH

1 minute read

Earnings

Preview: ProPhase Labs’s Earnings

By Benzinga Insights

Today, 12:44 PM

ProPhase Labs (NASDAQ:PRPH) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that ProPhase Labs will report an earnings per share (EPS) of $0.38.

PRPH